首页 > 最新文献

Duodecim; laaketieteellinen aikakauskirja最新文献

英文 中文
Data systems, genomic data and expertise of doctors. 数据系统,基因组数据和医生的专业知识。
Karoliina Snell, Ilpo Helén

Introduction of genomic data into health care requires willingness from physicians to adopt decision support systems as well as genomic information as part of their work. In the interview study, doctors' expectations about data systems and genomic data, as well as challenges for their utilization, are brought into light. Besides technical functionality, linking of data systems and the new knowledge mediated by them for clinicians also requires that doctors understand them as part of their professional expertise and thus useful.

将基因组数据引入卫生保健需要医生愿意采用决策支持系统以及基因组信息作为其工作的一部分。在访谈研究中,揭示了医生对数据系统和基因组数据的期望,以及它们在使用中面临的挑战。除了技术功能外,数据系统的链接以及由此为临床医生提供的新知识也要求医生将其理解为其专业知识的一部分,因此是有用的。
{"title":"Data systems, genomic data and expertise of doctors.","authors":"Karoliina Snell,&nbsp;Ilpo Helén","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Introduction of genomic data into health care requires willingness from physicians to adopt decision support systems as well as genomic information as part of their work. In the interview study, doctors' expectations about data systems and genomic data, as well as challenges for their utilization, are brought into light. Besides technical functionality, linking of data systems and the new knowledge mediated by them for clinicians also requires that doctors understand them as part of their professional expertise and thus useful.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 8","pages":"801-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35655928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caring communication - The impact of interpersonal communication between physician and patient. Can smileys measure the quality of communication? 关怀沟通——医患之间人际沟通的影响。微笑能衡量沟通的质量吗?
Harry Köhler, Päivi Rautava, Ville Vuorinen

The importance of communication in medical practice is widely recognized, but what is good communication in patient encounter? Feedback and surveys based on patient experience or "smileys" provide a narrow and often too insignificant view of communication. In addition to patient experience, communication benefits the information gathering by the physician and the patient, the patient's ability to promote his/her recovery, the physician's coping with workload, and the effectiveness of health care. In order to evaluate communication and improve it, one has to recognize the criteria and objectives of good communication. Medical communication that supports the rehabilitation of patients is reasonably good and responsible communication.

沟通在医疗实践中的重要性是公认的,但什么是良好的沟通在病人接触?基于患者经验或“笑脸”的反馈和调查提供了一种狭隘且往往过于微不足道的沟通观点。除了患者体验之外,沟通还有利于医生和患者收集信息、患者促进康复的能力、医生应对工作量以及医疗保健的有效性。为了评估和改进沟通,人们必须认识到良好沟通的标准和目标。支持病人康复的医疗沟通是合理的良好和负责任的沟通。
{"title":"Caring communication - The impact of interpersonal communication between physician and patient. Can smileys measure the quality of communication?","authors":"Harry Köhler,&nbsp;Päivi Rautava,&nbsp;Ville Vuorinen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The importance of communication in medical practice is widely recognized, but what is good communication in patient encounter? Feedback and surveys based on patient experience or \"smileys\" provide a narrow and often too insignificant view of communication. In addition to patient experience, communication benefits the information gathering by the physician and the patient, the patient's ability to promote his/her recovery, the physician's coping with workload, and the effectiveness of health care. In order to evaluate communication and improve it, one has to recognize the criteria and objectives of good communication. Medical communication that supports the rehabilitation of patients is reasonably good and responsible communication.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 8","pages":"735-41"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35656084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hope for better treatment in participating clinical drug trials. 希望参加临床药物试验能得到更好的治疗。
Tapani Keränen, Amos Pasternack, Arja Halkoaho

An informed consent is a prerequisite for participating in medical trials, whereby the person asked to take part in the trial shall understand what he is committing himself to, and that the consent is given voluntarily. Voluntariness can be undermined by so-called therapeutic optimism, i.e. belief in personal benefit brought about by the trial, as well as the difficulty of understanding how conventional treatment and the trial differ from each other, i.e. the so-called therapeutic misconception. The investigator, especially if he is also the attending physician, may influence the development of therapeutic misconception, because the participant may assume that the physician works as an investigator for the best benefit of the patients. It is important to recognize unrealistic optimism and therapeutic misconception of the trial, because for the participant they may result in disappointment and loss of confidence during the trial.

知情同意是参加医学试验的先决条件,据此,被要求参加试验的人应了解他所承诺的是什么,并且同意是自愿作出的。所谓的治疗乐观主义,即相信试验带来的个人利益,以及难以理解常规治疗与试验之间的差异,即所谓的治疗误解,都可能破坏自愿性。研究者,特别是如果他同时也是主治医生,可能会影响治疗误解的发展,因为参与者可能会认为医生作为研究者是为了患者的最佳利益而工作。重要的是要认识到不切实际的乐观主义和治疗误解的试验,因为对于参与者来说,他们可能导致失望和信心的丧失在试验期间。
{"title":"Hope for better treatment in participating clinical drug trials.","authors":"Tapani Keränen,&nbsp;Amos Pasternack,&nbsp;Arja Halkoaho","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An informed consent is a prerequisite for participating in medical trials, whereby the person asked to take part in the trial shall understand what he is committing himself to, and that the consent is given voluntarily. Voluntariness can be undermined by so-called therapeutic optimism, i.e. belief in personal benefit brought about by the trial, as well as the difficulty of understanding how conventional treatment and the trial differ from each other, i.e. the so-called therapeutic misconception. The investigator, especially if he is also the attending physician, may influence the development of therapeutic misconception, because the participant may assume that the physician works as an investigator for the best benefit of the patients. It is important to recognize unrealistic optimism and therapeutic misconception of the trial, because for the participant they may result in disappointment and loss of confidence during the trial.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 6","pages":"587-91"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35658604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of services due to problems related to mental health and substance abuse problems in Finland from 2012 to 2015. 2012年至2015年芬兰因精神健康和药物滥用问题而使用服务的情况。
Satu Viertiö, Airi Partanen, Risto Kaikkonen, Tommi Härkänen, Mauri Marttunen, Jaana Suvisaari

Introduction: Improving primary care services for mental health and substance abuse problems was one of the major goals of the Finnish national plan for mental health and substance abuse work.

Methods: The study data are drawn from the Regional Health and Well-being Study samples. Participants reported their health service use.

Results: Women and young adults used more mental health services than did men and older citizens. However, a significant proportion of those with mental health problems had not used any health services.

Conclusions: More attention should be paid on reducing the stigma associated to mental health and substance abuse problems both within the health care system and the society.

导言:改善精神健康和药物滥用问题的初级保健服务是芬兰精神健康和药物滥用工作国家计划的主要目标之一。方法:研究数据来源于区域健康与福祉研究样本。参与者报告了他们的医疗服务使用情况。结果:女性和年轻人比男性和老年人使用更多的心理健康服务。然而,很大一部分有精神健康问题的人没有使用过任何保健服务。结论:在卫生保健系统和社会中,应更多地关注减少与精神卫生和药物滥用问题相关的耻辱。
{"title":"The use of services due to problems related to mental health and substance abuse problems in Finland from 2012 to 2015.","authors":"Satu Viertiö,&nbsp;Airi Partanen,&nbsp;Risto Kaikkonen,&nbsp;Tommi Härkänen,&nbsp;Mauri Marttunen,&nbsp;Jaana Suvisaari","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Improving primary care services for mental health and substance abuse problems was one of the major goals of the Finnish national plan for mental health and substance abuse work.</p><p><strong>Methods: </strong>The study data are drawn from the Regional Health and Well-being Study samples. Participants reported their health service use.</p><p><strong>Results: </strong>Women and young adults used more mental health services than did men and older citizens. However, a significant proportion of those with mental health problems had not used any health services.</p><p><strong>Conclusions: </strong>More attention should be paid on reducing the stigma associated to mental health and substance abuse problems both within the health care system and the society.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 3","pages":"292-300"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35224148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on Current Care Guideline: Periodontitis. 当前护理指南的更新:牙周炎。

Periodontitis is common in the adult Finnish population. Also the prevalence of peri-implant diseases increases. As symptoms are rare, affected patients seldom seek dental care but require attention through the health care system. A careful periodontal screening, including risk assessment, is essential. Individual brushing and interdental cleaning instructions, as well as tobacco counseling, are important in preventing and treating these diseases, Early signs of periodontitis are indication for treatment, including necessary maintenance visits, preventing the severe periodontitis and its harmful consequences for the patient's dentition and general health.

牙周炎在芬兰成年人中很常见。此外,种植体周围疾病的患病率也在增加。由于症状罕见,受影响的患者很少寻求牙科护理,而是需要通过卫生保健系统进行关注。仔细的牙周筛查,包括风险评估,是必不可少的。个人刷牙和牙间清洁指导,以及烟草咨询,对预防和治疗这些疾病很重要。牙周炎的早期迹象是治疗的指征,包括必要的维护访问,防止严重的牙周炎及其对患者的牙齿和一般健康的有害后果。
{"title":"Update on Current Care Guideline: Periodontitis.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Periodontitis is common in the adult Finnish population. Also the prevalence of peri-implant diseases increases. As symptoms are rare, affected patients seldom seek dental care but require attention through the health care system. A careful periodontal screening, including risk assessment, is essential. Individual brushing and interdental cleaning instructions, as well as tobacco counseling, are important in preventing and treating these diseases, Early signs of periodontitis are indication for treatment, including necessary maintenance visits, preventing the severe periodontitis and its harmful consequences for the patient's dentition and general health.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 3","pages":"311-2"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35310767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antipsychotic drug-induced hypoglycemia and hypothermia. 抗精神病药物引起的低血糖和低温。
Aki Käräjämäki, Timo Lauri, Tapani Ebeling

This case report comprises three cases of antipsychotic drug-induced hypoglycemia and hypothermia. The mechanisms behind these side-effects are not known, but in hypoglycemia we describe signs of inappropriate insulin secretion. We assume that antipsychotic drug-induced hypoglycemia and hypothermia are underdiagnosed. Antipsychotic drugs are, however, widely used and these rare adverse-effects may occur in the clinical practice. It is of utmost importance to measure blood glucose and body temperature of patients taking these drugs who have unspecific symptoms.

本病例报告包括3例抗精神病药物引起的低血糖和低体温。这些副作用背后的机制尚不清楚,但在低血糖中,我们描述了胰岛素分泌不当的迹象。我们假设抗精神病药物引起的低血糖和低体温未被诊断。然而,抗精神病药物被广泛使用,这些罕见的不良反应可能在临床实践中发生。对于服用这些药物的患者,如果症状不明确,测量血糖和体温至关重要。
{"title":"Antipsychotic drug-induced hypoglycemia and hypothermia.","authors":"Aki Käräjämäki,&nbsp;Timo Lauri,&nbsp;Tapani Ebeling","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This case report comprises three cases of antipsychotic drug-induced hypoglycemia and hypothermia. The mechanisms behind these side-effects are not known, but in hypoglycemia we describe signs of inappropriate insulin secretion. We assume that antipsychotic drug-induced hypoglycemia and hypothermia are underdiagnosed. Antipsychotic drugs are, however, widely used and these rare adverse-effects may occur in the clinical practice. It is of utmost importance to measure blood glucose and body temperature of patients taking these drugs who have unspecific symptoms.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 3","pages":"301-4"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35224174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Graft-versus-host disease in stem cell transplantation. 干细胞移植中的移植物抗宿主病。
Mervi Taskinen, Samppa Ryhänen, Kim Vettenranta

Graft-versus-host disease (GvHD) remains a major treatment-related risk in patients undergoing stem cell transplantation. Although advances in HLA-typing and graft types have reduced the risk of GvHD, a breakthrough in the treatment of severe GvHD is still lacking. Allogenic stem cell transplant has potentially beneficial immunological effects on the malignant disease necessitating transplantation, and the importance of these effects must be considered when treating GvHD.

移植物抗宿主病(GvHD)仍然是干细胞移植患者的主要治疗相关风险。尽管hla分型和移植物类型的进步降低了GvHD的风险,但在治疗严重GvHD方面仍然缺乏突破。同种异体干细胞移植对需要移植的恶性疾病具有潜在的有益免疫作用,在治疗GvHD时必须考虑到这些作用的重要性。
{"title":"Graft-versus-host disease in stem cell transplantation.","authors":"Mervi Taskinen,&nbsp;Samppa Ryhänen,&nbsp;Kim Vettenranta","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Graft-versus-host disease (GvHD) remains a major treatment-related risk in patients undergoing stem cell transplantation. Although advances in HLA-typing and graft types have reduced the risk of GvHD, a breakthrough in the treatment of severe GvHD is still lacking. Allogenic stem cell transplant has potentially beneficial immunological effects on the malignant disease necessitating transplantation, and the importance of these effects must be considered when treating GvHD.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 3","pages":"251-8"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35310219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardial fluid: assessment and examination. 心包积液:评估和检查。
Anu Turpeinen, Marja Hedman

Pericardial fluid is a common finding on echocardiography. Less than 10 mm of fluid on ultrasound scan is not necessarily associated with any significant illness. Clinical examination, blood count, renal and liver enzymes and thyroid function tests as well as inflammatory marker tests are often adequate for a patient who is in good health. A significant amount of fluid requires further investigations, especially in a symptomatic patient. Cancers, infections and various systemic diseases are the most common causes of prominent effusion.

心包积液是超声心动图上常见的发现。超声扫描显示小于10mm的液体不一定与任何重大疾病有关。对于健康状况良好的病人来说,临床检查、血球计数、肾和肝酶以及甲状腺功能检查以及炎症标志物检查通常就足够了。大量的液体需要进一步的检查,特别是在有症状的病人中。癌症、感染和各种全身性疾病是引起突出积液的最常见原因。
{"title":"Pericardial fluid: assessment and examination.","authors":"Anu Turpeinen,&nbsp;Marja Hedman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pericardial fluid is a common finding on echocardiography. Less than 10 mm of fluid on ultrasound scan is not necessarily associated with any significant illness. Clinical examination, blood count, renal and liver enzymes and thyroid function tests as well as inflammatory marker tests are often adequate for a patient who is in good health. A significant amount of fluid requires further investigations, especially in a symptomatic patient. Cancers, infections and various systemic diseases are the most common causes of prominent effusion.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 4","pages":"403-10"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35310774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National vaccination program - a success story of public health and economy. 国家疫苗接种计划——公共卫生和经济的成功案例。
Heini Salo, Terhi Kilpi

The savings in treatment costs generated by disease cases prevented by the national vaccination program exceed the costs of the vaccination program by at least 60 million euros. In addition, other costs due to contracting the illness are avoided. Vaccinations serve the purpose of both increasing well-being and releasing resources for other uses. Financial support of vaccinations through the health insurance system would be costly and targetted to those with the ability to pay. Public funds should be directed to the development of a vaccination program. New vaccines coming on the market are expensive. Adding a new vaccine to the vaccination program is based on scientific evidence-based expert assessments and cost-effectiveness. In addition to preliminary assessments carried out in support of decision-making, the National Institute of Health and Welfare monitors by using population-based health registers the effectiveness and cost-effectiveness of the vaccination program. From the standpoint of transparency of decision-making it would be preferred that the decision-makers define a willingness to pay threshold below which an intervention would be accepted and lead to funding.

通过国家疫苗接种方案预防的疾病病例所节省的治疗费用至少比疫苗接种方案的费用多6000万欧元。此外,还避免了因感染疾病而产生的其他费用。接种疫苗的目的是增加福祉和释放资源用于其他用途。通过健康保险系统为疫苗接种提供财政支持将是昂贵的,而且针对的是那些有能力支付的人。公共资金应用于制定疫苗接种计划。新上市的疫苗价格昂贵。在疫苗接种规划中添加新疫苗是基于以科学为基础的专家评估和成本效益。除了为支持决策而进行的初步评估外,国家卫生和福利研究所还利用基于人口的健康登记来监测疫苗接种方案的效力和成本效益。从决策透明度的角度来看,决策者最好确定一个愿意支付的门槛,低于这个门槛,干预将被接受并导致供资。
{"title":"National vaccination program - a success story of public health and economy.","authors":"Heini Salo,&nbsp;Terhi Kilpi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The savings in treatment costs generated by disease cases prevented by the national vaccination program exceed the costs of the vaccination program by at least 60 million euros. In addition, other costs due to contracting the illness are avoided. Vaccinations serve the purpose of both increasing well-being and releasing resources for other uses. Financial support of vaccinations through the health insurance system would be costly and targetted to those with the ability to pay. Public funds should be directed to the development of a vaccination program. New vaccines coming on the market are expensive. Adding a new vaccine to the vaccination program is based on scientific evidence-based expert assessments and cost-effectiveness. In addition to preliminary assessments carried out in support of decision-making, the National Institute of Health and Welfare monitors by using population-based health registers the effectiveness and cost-effectiveness of the vaccination program. From the standpoint of transparency of decision-making it would be preferred that the decision-makers define a willingness to pay threshold below which an intervention would be accepted and lead to funding.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 10","pages":"977-83"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35655501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on Current Care guideline: Memory Disorders. 当前护理指南更新:记忆障碍。

Any complaint about memory should be examined. Diagnosis is based on international criteria. Basic evaluation consists of medical history, clinical evaluation, cognitive tests and brain imaging. When a diagnosis of Alzheimer's disease (AD), AD with cerebrovascular disease or with Lewy Body disease (LBD), or Dementia associated with Parkinson's disease or LBD is made, evidence-based medical therapy (acetylcholine esterase inhibitor or memantine) is indicated as a part of comprehensive care. In frontotemporal degenerations, these drugs are ineffective. For severe behavioural disorders, other psychoactive medications can be applied if non-pharmacological treatments are not sufficient.

任何关于记忆的抱怨都应该检查一下。诊断依据国际标准。基础评估包括病史、临床评估、认知测试和脑成像。当诊断为阿尔茨海默病(AD), AD合并脑血管疾病或路易体病(LBD),或痴呆合并帕金森病或LBD时,循证医学治疗(乙酰胆碱酯酶抑制剂或美金刚)应作为综合护理的一部分。对于额颞叶变性,这些药物无效。对于严重的行为障碍,如果非药物治疗不够,可以使用其他精神活性药物。
{"title":"Update on Current Care guideline: Memory Disorders.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Any complaint about memory should be examined. Diagnosis is based on international criteria. Basic evaluation consists of medical history, clinical evaluation, cognitive tests and brain imaging. When a diagnosis of Alzheimer's disease (AD), AD with cerebrovascular disease or with Lewy Body disease (LBD), or Dementia associated with Parkinson's disease or LBD is made, evidence-based medical therapy (acetylcholine esterase inhibitor or memantine) is indicated as a part of comprehensive care. In frontotemporal degenerations, these drugs are ineffective. For severe behavioural disorders, other psychoactive medications can be applied if non-pharmacological treatments are not sufficient.</p>","PeriodicalId":72850,"journal":{"name":"Duodecim; laaketieteellinen aikakauskirja","volume":"133 8","pages":"756-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35656022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Duodecim; laaketieteellinen aikakauskirja
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1